companydata.dkcompanydata.dk

Novomedicon ApS: Financial statements 2024

CVR: 38818791

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Novomedicon ApS (CVR 38818791) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -7,538 and a net result of DKK -7,538 compared with DKK -7,262 the year before. Equity in the 2024 report amounted to DKK 12,723. The solvency ratio was 1.7%. The company had 1 employee in the financial year.

Gross Profit
DKK -7,538
Profit/Loss
DKK -7,538
Equity
DKK 12,723
Total Assets
DKK 741,526
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--8K-8K13K1
2023--7K-7K20K1
2022--7K-7K28K-
2021---52235K-
2020-0-5K-5K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Novomedicon ApS: The 2023 annual report is outJul 1, 2024

Novomedicon ApS has published its annual report for 2023. Gross profit came to DKK -7,258, and the net result was DKK -7,262.

About Novomedicon ApS

Novomedicon ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Novomedicon IVS. The management consists of Jens Dahlgaard Hove. The company is owned by Jens Dahlgaard Hove. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,598 and a net result of DKK -7,598 compared with DKK -7,538 the year before. Equity in the 2025 report amounted to DKK 5,125.

Source: annual report 2025, Danish Business Authority

Other financial years